Symphogen is the older company (2000 vs 2019).
Side-by-Side Comparison
| Metric | Symphogen | Transcenta |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2019 |
| Headquarters | ||
| Headquarters | Ballerup, Denmark | Princeton, United States |
| Employees | ||
| Employees | 188 | 94 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Debt Financing | IPO |
| Total Funding | ||
| Total Funding | $314.00M | $178.74M |
| Funding Rounds | ||
| Funding Rounds | 10 | 5 |
| Services | ||
| Services | Not tracked yet | Biological Product Development, Antibody Generation, Clinical Research, Biotechnology Manufacturing, Partnering and Licensing |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Research Institutions, Global Healthcare Industry |
| Taxonomy | ||
| Taxonomy | Biologics Development, Antibodies, Oncology, Immune-oncology, R&D Strategy, Clinical Stages, Compounds, Therapies, Cancer Treatment, Drug Development | Biopharmaceutical, Antibody Biotherapeutics, Clinical Stage, Oncology, Bone Disorders, Kidney Disorders, Drug Discovery, R&D, Biomanufacturing, Translational Research, Process Development, Therapeutic Antibodies, Clinical Development, External Partnering, Mergers And Acquisitions |
| Website | ||
| Website | symphogen.com | transcenta.com |
About Symphogen
Symphogen: Symphogen A/S, a Servier company and the Centre of Excellence for Antibodies, operates within in research, early clinical stages and CMC biologics development from research to market. Supporting Servier’s commitment to improve patients health and the R&D strategy within oncology and immun...
About Transcenta
Transcenta, with the slogan INNOVATE TO EXCEL, is a clinical-stage biopharmaceutical company committed to the full integration of antibody-based biotherapeutics discovery, research, development, and manufacturing. Founded in 2019, Transcenta has made significant strides in the industry, solidifying...
We will tell you when either one moves
BounceWatch watches Symphogen and Transcenta for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Symphogen and Transcenta — by email.
Frequently Asked Questions
Compare Symphogen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Symphogen on 12 Sep 2024, and Transcenta on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.